[1]
Saheed Olanrewaju Afolabi, Joy Folahan, Olalekan Agede, and Olufunke Olorundare, “Combined Intranasal Insulin/Saxagliptin/Metformin Therapies Ameliorates the Effect of Combined Oral Contraceptives (Cos)-Induced Metabolic Syndrome (MetS) with a Major Target on Glucose Metabolism in Adult Female Wistar Rats: A Recent Study”, NHMMR-V12, pp. 91–107, Jun. 2022.